The Evolution of Chemical High-Throughput Experimentation To Address Challenging Problems in Pharmaceutical Synthesis
Тип публикации: Journal Article
Дата публикации: 2017-11-27
scimago Q1
wos Q1
БС1
SJR: 5.433
CiteScore: 30.7
Impact factor: 17.7
ISSN: 00014842, 15204898
PubMed ID:
29172435
General Chemistry
General Medicine
Краткое описание
The structural complexity of pharmaceuticals presents a significant challenge to modern catalysis. Many published methods that work well on simple substrates often fail when attempts are made to apply them to complex drug intermediates. The use of high-throughput experimentation (HTE) techniques offers a means to overcome this fundamental challenge by facilitating the rational exploration of large arrays of catalysts and reaction conditions in a time- and material-efficient manner. Initial forays into the use of HTE in our laboratories for solving chemistry problems centered around screening of chiral precious-metal catalysts for homogeneous asymmetric hydrogenation. The success of these early efforts in developing efficient catalytic steps for late-stage development programs motivated the desire to increase the scope of this approach to encompass other high-value catalytic chemistries. Doing so, however, required significant advances in reactor and workflow design and automation to enable the effective assembly and agitation of arrays of heterogeneous reaction mixtures and retention of volatile solvents under a wide range of temperatures. Associated innovations in high-throughput analytical chemistry techniques greatly increased the efficiency and reliability of these methods. These evolved HTE techniques have been utilized extensively to develop highly innovative catalysis solutions to the most challenging problems in large-scale pharmaceutical synthesis. Starting with Pd- and Cu-catalyzed cross-coupling chemistry, subsequent efforts expanded to other valuable modern synthetic transformations such as chiral phase-transfer catalysis, photoredox catalysis, and C-H functionalization. As our experience and confidence in HTE techniques matured, we envisioned their application beyond problems in process chemistry to address the needs of medicinal chemists. Here the problem of reaction generality is felt most acutely, and HTE approaches should prove broadly enabling. However, the quantities of both time and starting materials available for chemistry troubleshooting in this space generally are severely limited. Adapting to these needs led us to invest in smaller predefined arrays of transformation-specific screening "kits" and push the boundaries of miniaturization in chemistry screening, culminating in the development of "nanoscale" reaction screening carried out in 1536-well plates. Grappling with the problem of generality also inspired the exploration of cheminformatics-driven HTE approaches such as the Chemistry Informer Libraries. These next-generation HTE methods promise to empower chemists to run orders of magnitude more experiments and enable "big data" informatics approaches to reaction design and troubleshooting. With these advances, HTE is poised to revolutionize how chemists across both industry and academia discover new synthetic methods, develop them into tools of broad utility, and apply them to problems of practical significance.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Топ-30
Журналы
|
5
10
15
20
25
|
|
|
Organic Process Research and Development
21 публикация, 7.55%
|
|
|
Angewandte Chemie - International Edition
15 публикаций, 5.4%
|
|
|
Angewandte Chemie
15 публикаций, 5.4%
|
|
|
Journal of the American Chemical Society
14 публикаций, 5.04%
|
|
|
Journal of Organic Chemistry
13 публикаций, 4.68%
|
|
|
ACS Catalysis
13 публикаций, 4.68%
|
|
|
Nature Communications
9 публикаций, 3.24%
|
|
|
Reaction Chemistry and Engineering
9 публикаций, 3.24%
|
|
|
Chemical Science
8 публикаций, 2.88%
|
|
|
Digital Discovery
6 публикаций, 2.16%
|
|
|
Chemistry - A European Journal
5 публикаций, 1.8%
|
|
|
Chemical Reviews
5 публикаций, 1.8%
|
|
|
ACS Medicinal Chemistry Letters
5 публикаций, 1.8%
|
|
|
Chemistry - Methods
4 публикации, 1.44%
|
|
|
Accounts of Chemical Research
4 публикации, 1.44%
|
|
|
Organic Letters
4 публикации, 1.44%
|
|
|
RSC Medicinal Chemistry
4 публикации, 1.44%
|
|
|
Nature Chemistry
3 публикации, 1.08%
|
|
|
Chem
3 публикации, 1.08%
|
|
|
Tetrahedron
3 публикации, 1.08%
|
|
|
Organometallics
3 публикации, 1.08%
|
|
|
ACS Central Science
3 публикации, 1.08%
|
|
|
Chemical Communications
3 публикации, 1.08%
|
|
|
Science
3 публикации, 1.08%
|
|
|
Nature Synthesis
3 публикации, 1.08%
|
|
|
Inorganic Chemistry
2 публикации, 0.72%
|
|
|
Nature Protocols
2 публикации, 0.72%
|
|
|
Scientific Reports
2 публикации, 0.72%
|
|
|
Communications Chemistry
2 публикации, 0.72%
|
|
|
5
10
15
20
25
|
Издатели
|
20
40
60
80
100
120
|
|
|
American Chemical Society (ACS)
101 публикация, 36.33%
|
|
|
Wiley
55 публикаций, 19.78%
|
|
|
Royal Society of Chemistry (RSC)
40 публикаций, 14.39%
|
|
|
Springer Nature
38 публикаций, 13.67%
|
|
|
Elsevier
23 публикации, 8.27%
|
|
|
MDPI
7 публикаций, 2.52%
|
|
|
American Association for the Advancement of Science (AAAS)
4 публикации, 1.44%
|
|
|
Georg Thieme Verlag KG
2 публикации, 0.72%
|
|
|
Beilstein-Institut
2 публикации, 0.72%
|
|
|
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 публикация, 0.36%
|
|
|
Research Square Platform LLC
1 публикация, 0.36%
|
|
|
Taylor & Francis
1 публикация, 0.36%
|
|
|
Mary Ann Liebert
1 публикация, 0.36%
|
|
|
Institute of Electrical and Electronics Engineers (IEEE)
1 публикация, 0.36%
|
|
|
20
40
60
80
100
120
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
278
Всего цитирований:
278
Цитирований c 2025:
50
(17.99%)
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Скопировать
Krska S. W. et al. The Evolution of Chemical High-Throughput Experimentation To Address Challenging Problems in Pharmaceutical Synthesis // Accounts of Chemical Research. 2017. Vol. 50. No. 12. pp. 2976-2985.
ГОСТ со всеми авторами (до 50)
Скопировать
Krska S. W., Dirocco D. A., Dreher S. D., Shevlin M. The Evolution of Chemical High-Throughput Experimentation To Address Challenging Problems in Pharmaceutical Synthesis // Accounts of Chemical Research. 2017. Vol. 50. No. 12. pp. 2976-2985.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.1021/acs.accounts.7b00428
UR - https://doi.org/10.1021/acs.accounts.7b00428
TI - The Evolution of Chemical High-Throughput Experimentation To Address Challenging Problems in Pharmaceutical Synthesis
T2 - Accounts of Chemical Research
AU - Krska, Shane W.
AU - Dirocco, Daniel A
AU - Dreher, Spencer D.
AU - Shevlin, Michael
PY - 2017
DA - 2017/11/27
PB - American Chemical Society (ACS)
SP - 2976-2985
IS - 12
VL - 50
PMID - 29172435
SN - 0001-4842
SN - 1520-4898
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2017_Krska,
author = {Shane W. Krska and Daniel A Dirocco and Spencer D. Dreher and Michael Shevlin},
title = {The Evolution of Chemical High-Throughput Experimentation To Address Challenging Problems in Pharmaceutical Synthesis},
journal = {Accounts of Chemical Research},
year = {2017},
volume = {50},
publisher = {American Chemical Society (ACS)},
month = {nov},
url = {https://doi.org/10.1021/acs.accounts.7b00428},
number = {12},
pages = {2976--2985},
doi = {10.1021/acs.accounts.7b00428}
}
Цитировать
MLA
Скопировать
Krska, Shane W., et al. “The Evolution of Chemical High-Throughput Experimentation To Address Challenging Problems in Pharmaceutical Synthesis.” Accounts of Chemical Research, vol. 50, no. 12, Nov. 2017, pp. 2976-2985. https://doi.org/10.1021/acs.accounts.7b00428.